Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles

Autor: Kevin N. Sheth, Haitian Zhao, Yiyun Huang, Jun Liu, Pan Zou, Ann T. Chen, Zeming Chen, Yang Xin, W. Taylor Kimberly, Jonathan Avery, Jiangbing Zhou, Daniel Holden, Fuyao Liu, Keunpoong Lim, Songye Li, Chao Ma, Richard E. Carson, Shenqi Zhang, Gang Deng, J. Marc Simard, Qianxue Chen, Fengyi Du
Rok vydání: 2019
Předmět:
Male
antioxidant
Antioxidant
Combination therapy
medicine.medical_treatment
Drug delivery to the brain
Medicine (miscellaneous)
Brain Edema
Pharmacology
Antioxidants
combination therapy
Rats
Sprague-Dawley

Mice
03 medical and health sciences
chemistry.chemical_compound
Drug Delivery Systems
0302 clinical medicine
Pharmacotherapy
betulinic acid
Positron Emission Tomography Computed Tomography
Edema
Betulinic acid
Glyburide
ischemic stroke
Animals
Humans
Medicine
Pharmacology
Toxicology and Pharmaceutics (miscellaneous)

Stroke
030304 developmental biology
0303 health sciences
business.industry
Eucommiaceae
medicine.disease
Triterpenes
Rats
3. Good health
Mice
Inbred C57BL

chemistry
Ischemic stroke
Nanoparticles
Drug Therapy
Combination

medicine.symptom
Pentacyclic Triterpenes
business
030217 neurology & neurosurgery
Drugs
Chinese Herbal

Research Paper
Zdroj: Theranostics
ISSN: 1838-7640
DOI: 10.7150/thno.35791
Popis: Stroke is a deadly disease without effective pharmacotherapies, which is due to two major reasons. First, most therapeutics cannot efficiently penetrate the brain. Second, single agent pharmacotherapy may be insufficient and effective treatment of stroke requires targeting multiple complementary targets. Here, we set to develop single component, multifunctional nanoparticles (NPs) for targeted delivery of glyburide to the brain for stroke treatment. Methods: To characterize the brain penetrability, we radiolabeled glyburide, intravenously administered it to stroke- bearing mice, and determined its accumulation in the brain using positron emission tomography-computed tomography (PET/CT). To identify functional nanomaterials to improve drug delivery to the brain, we developed a chemical extraction approach and tested it for isolation of nanomaterials from E. ulmoides, a medicinal herb. To assess the therapeutic benefits, we synthesized glyburide-loaded NPs and evaluated them in stroke- bearing mice. Results: We found that glyburide has a limited ability to penetrate the ischemic brain. We identified betulinic acid (BA) capable of forming NPs, which, after intravenous administration, efficiently penetrate the brain and significantly reduce ischemia-induced infarction as an antioxidant agent. We demonstrated that BA NPs enhance delivery of glyburide, leading to therapeutic benefits significantly greater than those achieved by either glyburide or BA NPs. Conclusion: This study suggests a new direction to identify functional nanomaterials and a simple approach to achieving anti-edema and antioxidant combination therapy. The resulting glyburide- loaded BA NPs may be translated into clinical applications to improve clinical management of stroke.
Databáze: OpenAIRE